Home > Boards > US Listed > Biotechs >

Oragenics (OGEN)

OGEN RSS Feed
Add OGEN Price Alert      Hide Sticky   Hide Intro
Moderator: Golden_Cross, TenTimesPay, TAB78
Search This Board: 
Last Post: 2/24/2021 12:50:13 PM - Followers: 92 - Board type: Free - Posts Today: 0

 

ORAGENICS - NYSE Market

https://www.oragenics.com/

""Oragenics is focused on the creation of the TerraCoV2 immunization product candidate to combat the novel coronavirus pandemic and the further development of effective treatments for novel antibiotics against infectious disease. In addition, Oragenics, Inc. has established an exclusive worldwide channel collaboration with Precigen, Inc., a synthetic biology company. The collaborations allow Oragenics access to Precigen's proprietary technologies toward the goal of accelerating the development of much needed new antibiotics that can work against resistant strains of bacteria.""

https://www.oragenics.com/about

 

Management Team

Alan Joslyn, Ph.D.

President and Chief Executive Officer

Dr. Joslyn was a partner in Lazarus Pharmaceuticals. Prior to that he served as the Chief Executive Officer and Director of several privately held companies including Edusa Pharmaceuticals and Sentinella Pharmaceuticals and prior to that he was the Senior Vice-President Research and Development of Penwest Pharmaceuticals and also held senior drug development positions with Johnson & Johnson.

Michael Sullivan

Chief Financial Officer

Mr. Sullivan has served as our interim principal executive officer since October 30, 2014 and served as our Chief Financial Officer, Secretary and Treasurer since February 6, 2012. Mr. Sullivan has held senior level financial positions for several publicly and privately held businesses including Utek Corporation, eANGLER, and HSN Direct International Limited. Most recently, he was the Group Financial Officer for the Investigative Services and Litigation Consulting Services segment of First Advantage Corporation. Mr. Sullivan is a Florida Certified Public Accountant. He graduated from the Florida State University with a Bachelor of Science in Accounting and a Master of Business Administration.

Dr. Martin Handfield

Senior Vice President of Discovery Research

Dr. Handfield is, the Company’s Senior Vice President of Discovery Research and previously has served as our Director of Research and Development. Prior to joining our Company, Dr. Handfield held a position as Tenured Associate Professor at the Center for Molecular Microbiology and the Department of Oral Biology at the University of Florida College of Dentistry, where he co-invented IVIAT and co-founded ivi Gene Corp. and Epicure Corp. to commercialize this and related technologies. Dr. Handfield holds a B.S. degree in Biochemistry, and a MS degree and PhD in Microbiology and Immunology from the Université Laval College of Medicine in Canada, and did postdoctoral training at the University of Florida.

https://www.oragenics.com/about/management-team


--------------------------------------------------------------------------------------------------------------------------------------------
 
OTC - NEWS
 
http://Oragenics enters into material transfer agreement for COVID-19 vaccine adjuvantSeeking Alpha | 01/07/2021

http://Oragenics Enters Into Material Transfer Agreement With Adjuvance Technologies for COVID-19 Vaccine AdjuvantBUSINESS WIRE | 01/07/2021

http://Oragenics, Inc. Announces $6.5 Million Registered Direct OfferingBUSINESS WIRE | 12/24/2020

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------

OTC - Disclosure's
https://www.otcmarkets.com/stock/OGEN/disclosure

-------------------------------------------------------------------------------------------------------------------------------------------------------------------

Companies News
http://Oragenics working on treatment for oral mucositis with promising AG013 product December 12, 2019

http://Oragenics making 'great progress' enrolling patients in oral mucositis clinical trial October 23, 2019

http://Oragenics, Inc. using Genetically Modified Lactococcus Bacteria found in Yogurt and Milk to create Lantibiotics and Prevent Oral Mucositis May 13, 2019

http://Biotech Outlook 2019: Will the Pressure Continue? December 19, 2018

----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
 

Press Releases

Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine

August 20, 2020
 

See this link to read above Press Release or see more - https://www.oragenics.com/news-media/press-releases

----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
 

Publications

 
Molecular mechanisms of pore formation and membrane disruption by the antimicrobial lantibiotic peptide Mutacin 1140
Preclinical evaluation of the maximum tolerated dose and toxicokinetics of enteric-coated lantibiotic OG253 capsules
Pharmacological, Toxicological, and Dose Range Assessment of OG716, a Novel Lantibiotic for the Treatment of <em>Clostridium difficile</em>-Associated Infection
<i>Chemical Biology & Drug Design</i> Cover Image
Blueprints for the rational design of therapeutic mutacin 1140 variants
OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections
Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection
Human serum binding and its effect on the pharmacodynamics of the lantibiotic MU1140
Pharmacokinetic and Pharmacodynamic Evaluation of the Lantibiotic MU1140
Development and validation of a LC–MS quantification method for the lantibiotic MU1140 in rat plasma



 

See this link to read above publications - https://www.oragenics.com/news-media/publications


 

 




 

 

See this link to read above publications - https://www.oragenics.com/news-media/publications?page=2

 

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

 

Abstracts

Engineering Improved Variants of Mutacin 1140 by Saturation Mutagenesis
Development of OG716, a Novel Lantibiotic Against Clostridium difficile
 

 




 

See this link to read above Abstracts - https://www.oragenics.com/news-media/abstracts

----------------------------------------------------------------------------------------------------------------------------------------------------------
Share Structure
A/S
  

O/S    51,244,130  01/07/2020

Restricted 

Unrestricted 

Held at DTC 

Float 

OGEN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#707  Sticky Note OGEN Lots of news out Yesterday, gonna be TAB78 01/08/21 09:16:43 AM
#762   I really hope but i also believe very Mountainman5 02/24/21 12:50:13 PM
#761   In my opinion, $ 10 is possible in Mountainman5 02/24/21 08:55:27 AM
#760   In my opinion, you can only buy and Mountainman5 02/24/21 08:43:53 AM
#759   10 Bagger 2021 - Big support from J. Mountainman5 02/24/21 08:42:18 AM
#758   There is great hope in Oragenics!!!!!!!!!!!!!!!! Mountainman5 02/21/21 01:20:05 PM
#757   NOVAVAX - 1/20 $ 7 - 2/21 $ 290 Mountainman5 02/20/21 01:33:31 PM
#756   $OGEN. A Director. outnabout 02/19/21 06:50:48 PM
#755   Ty outanabout traderjack1 02/19/21 06:44:22 PM
#754   $OGEN We have a form 4. https://ih.advfn.com/stock-market/AMEX/oragenics-OGEN/stock-news/84389250/ outnabout 02/19/21 06:32:38 PM
#753   Thanks D-bol 02/19/21 10:33:30 AM
#752   $OGEN The consensus is -.06 so a outnabout 02/19/21 07:23:16 AM
#751   Lets hope its tomorrow. You think its going D-bol 02/18/21 10:19:14 PM
#750   $OGEN. Not so sure they’re due. outnabout 02/18/21 09:54:13 PM
#749   Hope its good D-bol 02/18/21 09:30:24 PM
#748   Let's roll! Lowhndcpr 02/18/21 08:07:59 PM
#747   $OGEN Earnings tomorrow outnabout 02/18/21 05:29:28 PM
#746   I bought in. Call it a oakrock 02/17/21 06:37:51 PM
#745   Short selling spiked in OGEN over the past oxnous 02/09/21 10:15:20 PM
#744   * * $OGEN Video Chart 02-09-2021 * * ClayTrader 02/09/21 04:32:22 PM
#743   Added 2500 shares today, will see what happens. vikingzskillz 02/09/21 10:14:34 AM
#742   Yes, share are in short supply to cover DCALongRun 02/09/21 09:31:07 AM
#741   Time to squeeze em! waytoorandom 02/09/21 09:10:55 AM
#740   Rockying charlie, hit 1.98 this morning in the DCALongRun 02/09/21 07:22:45 AM
#739   Better site easier to read. DCALongRun 02/08/21 10:57:08 PM
#738   http://regsho.finra.org/CNMSshvol20210208.txt short interest[/tag DCALongRun 02/08/21 09:59:48 PM
#737   Wondering if there is a short position in oxnous 02/08/21 09:35:52 PM
#736   And away we go. :) retired early 02/08/21 07:40:31 PM
#735   * * $OGEN Video Chart 02-08-2021 * * ClayTrader 02/08/21 04:35:52 PM
#734   Loading here. Waiting on breakout!$$$ Jess070283 02/08/21 02:22:30 PM
#733   Got some more shares. FDA approval this will DCALongRun 02/08/21 12:55:43 PM
#732   Major accumulation happening now. Very tempting to be DCALongRun 02/08/21 08:06:08 AM
#731   Be sure to close any short positions right mistercellphoneman 02/08/21 04:21:06 AM
#730   OGEN will surprise a lot including me just lukin4winners 02/05/21 06:58:38 AM
#729   Price target is $2.50 DCALongRun 02/04/21 08:44:20 AM
#728   I love what you just said could have money 200 02/02/21 04:07:11 PM
#727   Added some first thing this morning. :) retired early 02/02/21 09:42:48 AM
#726   lot of insider selling in dec ......prospectus after dirtydozen911 02/02/21 09:17:42 AM
#725   Big news SARS-CoV-2 Spike Protein Licensed by Oragenics saj 02/02/21 08:01:02 AM
#724   * * $OGEN Video Chart 01-22-2021 * * ClayTrader 01/22/21 04:42:21 PM
#723   This comes back down to fill that gap littleharoldeh 01/22/21 10:47:24 AM
#722   32M $1.05 volume so far big move just starting lukin4winners 01/20/21 01:36:16 PM
#721   2.50-2.75 OCMillionaire 01/20/21 12:03:22 PM
#720   What your price target. $2? Greece1 01/20/21 11:58:09 AM
#719   Looking for another huge run up here. BigIbby 01/20/21 11:41:33 AM
#718   im loading heavy OCMillionaire 01/20/21 11:32:59 AM
#717   Can we run tmw ? Greece1 01/18/21 09:05:23 PM
#716   * * $OGEN Video Chart 01-14-2021 * * ClayTrader 01/14/21 04:07:55 PM
#715   What is the outstanding OS. Not clear. Any body idea Master Stocktrader 01/14/21 12:30:38 PM
#714   Yes it did nicely, good to see TAB78 01/14/21 11:29:02 AM
#713   Well it happened news out today traded as money 200 01/14/21 11:24:05 AM
PostSubject
Consent Preferences